Saptak Chem and Business Limited (BOM: 506906)

Saptak Chem and Business Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	-	-	0.84	0.37	0.74	-
Revenue Growth (YoY)	-	-	127.99%	-50.12%	-	-
Cost of Revenue	0	0	0.06	0.14	0.75	-
Gross Profit	-0	-0	0.78	0.23	-0.01	-
Selling, General & Admin	0.08	0.03	0.18	0.13	0.03	0.03
Other Operating Expenses	0.25	0.31	0.54	0.08	0.06	0.06
Operating Expenses	0.33	0.35	0.72	0.21	0.19	0.08
Operating Income	-0.33	-0.35	0.06	0.02	-0.2	-0.08
Other Non Operating Income (Expenses)	-0	-0	-0	0	-	-
Pretax Income	-0.33	-0.35	0.06	0.02	-0.2	-0.08
Net Income	-0.33	-0.35	0.06	0.02	-0.2	-0.08
Net Income to Common	-0.33	-0.35	0.06	0.02	-0.2	-0.08
Net Income Growth	-	-	190.00%	-	-	-
Shares Outstanding (Basic)	10	11	11	11	11	11
Shares Outstanding (Diluted)	10	11	11	11	11	11
Shares Change (YoY)	-17.79%	-	-	-	-	-
EPS (Basic)	-0.03	-0.03	0.01	0.00	-0.02	-0.01
EPS (Diluted)	-0.03	-0.03	0.01	0.00	-0.02	-0.01
EPS Growth	-	-	190.07%	-	-	-
Free Cash Flow	-7.18	-6.54	1.28	-1.19	0.08	-0.08
Free Cash Flow Per Share	-0.72	-0.61	0.12	-0.11	0.01	-0.01
Gross Margin	-	-	92.97%	62.77%	-1.97%	-
Operating Margin	-	-	7.15%	5.16%	-27.73%	-
Profit Margin	-	-	6.91%	5.43%	-27.73%	-
Free Cash Flow Margin	-	-	152.32%	-322.83%	10.99%	-
EBITDA	-	-0.25	0.16	0.12	-0.1	-
EBITDA Margin	-	-	19.19%	32.49%	-14.10%	-
D&A For EBITDA	-	0.1	0.1	0.1	0.1	-
EBIT	-0.33	-0.35	0.06	0.02	-0.2	-0.08
EBIT Margin	-	-	7.15%	5.16%	-27.73%	-
Revenue as Reported	-	-	0.84	0.37	0.74	-

Source: S&P Capital IQ. Standard template. Financial Sources.